1Alyson A.Miller, Ian L.Megson & Gillian A. Gray.Inducible nitric oxide synthase-derived supemxide contributes to hypereactivity in small mesenteric arteries from a rat model of chronic heart failure. British Journal of Pharmacology,2000,131:29 36.
3ELIZABETH MURPHY, CHARLES STEENBERGEN. Mechanisms Underlying Acute Protection From CardiacIschemia-Reperfusion Injury. Physiol Rev ,2008,88:581 -609.
4Arroyo CM, Kramer JH, Dickens BF, et al. Identification of free radicals in myocardial ischemia/repeffusion by spin trapping with nitrone DMPO. FEBS Lett.1987, 221:101 -104.
5Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic p_ostconditioning during reperfusion: comparison with ischemic preconditioning.Am J Physiol Heart Circ Physiol,2003,285: H579-H588.
6Laskey WK. Brief repetitive balloon Occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc lnterv, 2005,65 : 361-367.
7Zhi-Qing Zhao. Oxidative stress-elicited myocardial apoptosis during reperfusion. Current Opinion in Pharmacology,2004, 4:159 165.
8A. Valtchanova-Matchouganska, M. Gondwe, A. Nadar. The role of C-reactive protein in ischemia/reperfusion injury and preconditioning in a rat model of myocardial infarction. Life Sciences,2004, 75 : 901 -910.
9Yang XM, Proctor JB, Cui L, Krieg T, et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coil Cardiol, ,2004, 44:1103 -1110.
10Murry CE, Jennings RB, Reimer KA, et al. Preconditioning with ischemia :a delay of lethal cell injury in ischemic myocardium. Circuation, 1986,74:1124-1136.
二级参考文献38
1Alp NJ,McAteer MA,Khoo J,et al.Increased endothelial tetrahydrobiopterinsynthesis by targeted transgenic GTP-cyclohydrolase I overexpression reducesendothelial dysfunction and atherosclerosis in ApoE-knockout mice[J].Arte-rioscler Thromb Vasc Biol,2004,24(3):445-450.
2Kanaya S,Ikeda H,Haramaki N,et al.Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation[J].Circulation,2001,104(20):2478-2484.
3Guzik TJ,Mussa S,Gastaldi D,et al.Mechanisms of increased vascular superoxide production in human diabetes mellitus:role of NADPH oxidase and endothelial nitric oxide synthase[J].Circulation,2002,105(14):1656-1662.
4Schinozaki K,Nishio Y,Okamura T,et al.Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats[J].Circulation,2000,87(7):566-573.
5Alp NJ,Mussa S,Khoo J,et al.Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression[J].J Clin Invest,2003,112(5):725-735.
6Meininger CJ,Marinos RS,Hatakeyama K,et al.Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency[J].Biochem J,2000,349:353-356.
7Yamashiro S,Noguchi K,Kuniyoshi Y,et al.Role of tetrahydrobiopterin on ischemia-reperfusion injury in isolated perfused rat hearts[J].J Cardiovasc Surg,2003,44(1):37-49.
9Hillinger S,Sandera P,Carborri GL,et al.Survival and graft function in a large animal lung transplant model after 30h preservation and substitution of nitric oxide pathway[J].Eur J Cardiothorac Surg,2001,20(3):508-513.
10Forgione MA,Loscalzo J.Oxidant stress as a critical determinant of endothelial function[J].Drug News Perspect,2000,13(9):523-529.
